Boehringer Ingelheim Animal Health

Boehringer Ingelheim Animal Health and Boehringer Ingelheim Vetmedica belong to the Boehringer Ingelheim group of companies. The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of 10.95 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development.

The animal health business is present in more than 20 countries including USA, Canada, France, Germany, UK, Italy, Spain, Mexico, the Nordic countries Japan and China. Since 1955, Boehringer Ingelheim Animal Health has been contributing to an adequate supply of safe, nutritious food and the promotion of the emotional and physical benefits arising from the human-animal bond and pet ownership.

Animal Health Portfolio

The Boehringer Ingelheim Animal Health portfolio includes biological, pharmaceutical and natural care products for a range of conditions affecting companion animals (dogs, cats, horses) and farm animals (cows, pigs). These include treatments for the management of acute and chronic pain, heart failure, osteoarthritis and respiratory disease in companion animals, and vaccines for a range of problem diseases in pigs.